Recent studies have significantly improved our understanding of the molecular mechanisms underlying different forms of AF, identifying novel opportunities for developing mechanism-based antiarrhythmic approaches including AF-specific ion-channel blockers, targeting of Ca2+-handling abnormalities (CaMKII, RyR2), and modulation of upstream pathways (notably inflammatory signaling). Here, RYR2 is linked to atrial fibrillation.